2Lau LF, Schachter JB, Seymour PA, et al. Tau protein phosphorylation as a therapeutic target in Alzheimer's disease[J]. Curr Top Med Chem, 2002 ,2(4) :395.
3Hamdane M, Smet C, Sambo AV, et al. Pinl: a therapeutic target in Alzheimer neurodegeneration [J]. J Mol Neurosci ,2002,19(3):275.
4Lau LF, Seymour PA, Sanner MA, et al. Cdk5 as a drug target for the treatment of Alzheimer's disease [J]. JMol Neurosci, 2002 ,19(3) :267.
5Tsai JY, Wolfe MS, Xia W. The search for gamma-secretase and development of inhibitors [J]. Curr Med Chem, 2002,9(11) :1087.
6Vassar R. Beta-Secretase (BACE) as a drug target for Alzheimer's disease [J]. Adv Drug Deliv Rev, 2002 ,54(12) :1589.
7Adessi C, Frossard MJ, Boissard C, et al. Pharmacological profiles of peptide drug candidates for the treatment of Alzheimer's disease[J]. JBiol Chem,2003 ,278(16) :13905.
8Matsuoka Y, Saito M, LaFrancois J, et al. Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to beta-amyloid [ J ]. J Neurosci,2003 ,23(1) :29.
9Pasinetti GM. Cyclooxygenase as a target for the antiamyloidogenic activities of nonsteroidal anti-inflammatory drugs in Alzheimer's disease[J]. Neurosignals, 2002 ,11(5) :293.
10Lee HG, Zhu X, Ghanbari HA, et al. Differential regulation of glutamate receptors in Alzheimer's disease [ J]. Neurosignals, 2002 , 11(5) :282.
